EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

Basit Öğe Kaydı
dc.contributor.authorBowlus, Christopher L.
dc.contributor.authorKowdley, Kris V.
dc.contributor.authorLevy, Cynthia
dc.contributor.authorAkarca, Ulus
dc.contributor.authorAlvares-Da-Silva, Mario Reis
dc.contributor.authorAndreone, Pietro
dc.contributor.authorArrese, Marco
dc.date.accessioned2024-08-31T07:50:57Z
dc.date.available2024-08-31T07:50:57Z
dc.date.issued2024
dc.departmentEge Üniversitesien_US
dc.description.abstract[Abstarct Not Available]en_US
dc.identifier.endpageE42en_US
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.issue2en_US
dc.identifier.startpageE40en_US
dc.identifier.urihttps://hdl.handle.net/11454/105438
dc.identifier.volume79en_US
dc.identifier.wosWOS:001271642700041en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240831_Uen_US
dc.titleEFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIALen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu